Trial Profile
A Phase II trial to investigate EP-201 in ovarian cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 18 May 2017
Price :
$35
*
At a glance
- Drugs EP 201 (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 18 May 2017 New trial record
- 10 May 2017 This trial is expected to begin in 2017, according to an EpiThany media release.